موكلوبيميد

موكلوبيميد هومثبط أكسيداز أحادي الأمين عكوس يستخدم في عدة بلدان من العالم مثل بريطانيا وأستراليا لعلاج الاضطراب الاكتئابي والقلق الاجتماعي.

المصادر

^ Fitton, A; Faulds, D; Goa, KL (April 1992). "Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness". Drugs. 43 (4): 561–596. doi:10.2165/00003495-199243040-00009. PMID 1377119.
↑ Freeman, H (December 1993). "Moclobemide". Lancet. 342 (8886–8887): 1528–1532. doi:10.1016/S0140-6736(05)80090-X. PMID 7902906.
↑ Schoerlin, MP; Mayersohn, M; Korn, A; Eggers, H (October 1987). "Disposition kinetics of moclobemide, a monoamine oxidase-A enzyme inhibitor: single and multiple dosing in normal subjects". Clinical Pharmacology and Therapeutics. 42 (4): 395–404. PMID 3665338.
^ Jauch, R; Griesser, E; Oesterhelt, G; Arnold, W; Meister, W; Ziegler, WH; Guentert, TW (1990). "Biotransformation of moclobemide in humans". Acta Psychiatrica Scandinavica Supplementum. 82 (S360): 87–90. doi:10.1111/j.1600-0447.1990.tb05344.x. PMID 2248086.
↑ Guentert, TW; Tucker, G; Korn, A; Pfefen, JP; Haefelfinger, P; Schoerlin, MP (1990). "Pharmacokinetics of moclobemide after single and multiple oral dosing with 150 milligrams ثلاثة times daily for 15 days". Acta Psychiatrica Scandinavica Supplementum. 82 (S360): 91–93. doi:10.1111/j.1600-0447.1990.tb05345.x. PMID 2248087.
^ Gex-Fabry, M; Balant-Gorgia, AE; Balant, LP (February 1995). "Potential of concentration monitoring data for a short half-life drug: analysis of pharmacokinetic variability for moclobemide". Therapeutic Drug Monitoring. 17 (1): 39–46. doi:10.1097/00007691-199502000-00007. PMID 7725375.
↑ نطقب:Cite isbn
^ Fulton B, Benfield P (September 1996). "Moclobemide. An update of its pharmacological properties and therapeutic use". Drugs. 52 (3): 450–74. doi:10.2165/00003495-199652030-00013. PMID 8875133.
^ نطقب:Cite isbn